title: Systematic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease.
authors.affiliation: Department of Medicines Management, Keele University, UK.
authors.forename: W
authors.initials: W
authors.lastname: Clark
authors.forename: J
authors.initials: J
authors.lastname: Raftery
authors.forename: F
authors.initials: F
authors.lastname: Song
authors.forename: P
authors.initials: P
authors.lastname: Barton
authors.forename: C
authors.initials: C
authors.lastname: Cummins
authors.forename: A
authors.initials: A
authors.lastname: Fry-Smith
authors.forename: A
authors.initials: A
authors.lastname: Burls
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000191:economics* / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000009:adverse effects / Q000191:economics* / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D003424:Crohn Disease / Q000188:drug therapy* / Q000191:economics; D016527:Drug Costs; D004341:Drug Evaluation; D006801:Humans; D000069285:Infliximab; D019057:Quality-Adjusted Life Years; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab